Revenue distribution of CanSino Biologics Inc. 2021, by market
In 2021, more than 70 percent of CanSino's 4.3 billion yuan revenue was generated by the international market. Thanks to the export sales of Convidecia, the company's single-dose COVID-19 vaccine, CanSino increased its annual revenue by more than 23,000 percent in 2021 and became a profitable business for the first time in many years.